Responses
Oral Presentations
Osteoarthritis: new horizons for treatment
OP0167 Efficacy and safety of CNTX-4975 in subjects with moderate to severe osteoarthritis knee pain: 24-week, randomized, double-blind, placebo-controlled, dose-ranging study
Compose a Response to This Article
Other responses
No responses have been published for this article.